glp 1 and lizard venom How a Venomous Desert Helped Lead Scientists to Ozempic The discovery of a digestion-slowing

Consequently, this escalating global burden of obesity is fueling the expansion of the market for GLP-1 agonist weight loss pharmaceuticals

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

Type 2 diabetes is the most common cause of CKD, and both diabetes and CKD are associated with increased all-cause mortality and increased rates of infection and cardiovascular events

Addressing these imbalances is essential to preserve normobiosis and mitigate downstream inflammatory risk

doi: 10.3389/fped.2022.1091571 22 AkazawaROtsukaSKatoIImadomeKITakitaJ

Antimicrobial Properties and Cytotoxicity of LL-37-Derived Synthetic Peptides to Treat Orthopedic Infections